Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Center Hamburg Eppendorf, Hamburg, Germany.
Center for Neurology, Neurosurgery and Psychiatry, Department of Psychiatry, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin, Germany.
Neurosci Biobehav Rev. 2016 Aug;67:137-46. doi: 10.1016/j.neubiorev.2015.12.015. Epub 2016 Jan 8.
Clinical observations in human autoimmune diseases such as multiple sclerosis (MS) suggest a pivotal role of sex-related factors in the etiopathogenesis. These include a female preponderance in MS incidence and an increasing sex bias over time, a parent-of-origin effect in MS inheritance, and the protective effect of pregnancy on disease activity. The complex interplay of factors contributing to these clinical phenomena, however, is incompletely understood and may include sex hormones as well as genetic or epigenetic sex differences. While genetic and hormonal effects are impossible to study independently in humans, novel mouse models have started to unravel the cause-effect relationship between individual sex-related factors and autoimmunity. Here, we present the evidence for mechanisms underlying sex differences in the immune system and the central nervous system (CNS) and how these might help to explain some of the clinically observed sex differences in MS. A better understanding of the molecular underpinnings may ultimately help to devise sex-specific treatment strategies as well as highlight novel avenues for therapy in both sexes.
在多发性硬化症(MS)等人类自身免疫性疾病的临床观察中,提示性别相关因素在发病机制中起着关键作用。这些因素包括 MS 发病率中女性的优势,以及随着时间的推移性别偏见的增加,MS 遗传中的亲本来源效应,以及妊娠对疾病活动的保护作用。然而,促成这些临床现象的复杂因素相互作用尚不完全清楚,其中可能包括性激素以及遗传或表观遗传性别差异。虽然在人类中不可能独立研究遗传和激素的影响,但新型小鼠模型已开始揭示个体性别相关因素与自身免疫之间的因果关系。在这里,我们提出了免疫系统和中枢神经系统(CNS)中性别差异的潜在机制的证据,以及这些机制如何有助于解释 MS 中一些临床观察到的性别差异。对分子基础的更好理解最终可能有助于制定针对特定性别的治疗策略,并突出两性治疗的新途径。